Lupin Pharmaceuticals Inc. has voluntarily recalled 46,479 bottles of Oseltamivir Phosphate for Oral Suspension (6 mg/mL). This prescription medication, commonly used to treat the flu, was found to have an impurity level that exceeded safety specifications during stability testing. Consumers should contact their healthcare provider or pharmacist regarding this recall and for guidance on their treatment.
The product failed long-term stability testing due to an out-of-specification result for 'Impurity C.' This means the drug may degrade faster than expected or contain unintended chemical byproducts, which could potentially impact the effectiveness or safety of the medication over time.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.